XML 61 R49.htm IDEA: XBRL DOCUMENT v3.22.4
License Agreements - Lily (Details) - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended 145 Months Ended
Jun. 30, 2022
Mar. 31, 2022
May 31, 2019
Dec. 31, 2009
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Mar. 31, 2017
License agreements                  
Revenues         $ 3,394,635 $ 2,986,267 $ 2,666,702    
United States                  
License agreements                  
Revenues         3,200,000 2,900,000 2,600,000    
Europe                  
License agreements                  
Revenues         147,000 124,100 105,000    
Eli Lilly                  
License agreements                  
Revenues         70,000 50,000 30,000    
Eli Lilly | Development Milestones                  
License agreements                  
Amount recognized and received for the achievement of a predefined milestone               $ 149,000  
Eli Lilly | Development Milestones | Maximum                  
License agreements                  
Upfront and immediate milestone payment to be received under license agreement       $ 150,000          
Eli Lilly | Regulatory Milestones                  
License agreements                  
Amount recognized and received for the achievement of a predefined milestone               335,000  
Eli Lilly | Regulatory Milestones | Maximum                  
License agreements                  
Upfront and immediate milestone payment to be received under license agreement       365,000          
Eli Lilly | Commercialization Milestones                  
License agreements                  
Amount recognized and received for the achievement of a predefined milestone               $ 50,000  
Eli Lilly | Commercialization Milestones | Maximum                  
License agreements                  
Upfront and immediate milestone payment to be received under license agreement       $ 150,000          
Eli Lilly | OLUMIANT                  
License agreements                  
Revenues         $ 134,500 $ 220,900 $ 110,900    
Eli Lilly | OLUMIANT | Regulatory Milestones | United States                  
License agreements                  
Amount recognized and received for the achievement of a predefined milestone $ 40,000                
Eli Lilly | OLUMIANT | Regulatory Milestones | Europe                  
License agreements                  
Amount recognized and received for the achievement of a predefined milestone 20,000                
Eli Lilly | OLUMIANT | Regulatory Milestones | Japan                  
License agreements                  
Amount recognized and received for the achievement of a predefined milestone $ 10,000                
Eli Lilly | GVHD                  
License agreements                  
Additional milestone payments under the license agreement                 $ 40,000
Eli Lilly | GVHD | Regulatory Milestones                  
License agreements                  
Milestone payment made under license agreement     $ 20,000            
Eli Lilly | GVHD | Regulatory Milestones | Europe                  
License agreements                  
Milestone payment made under license agreement   $ 20,000